Individuals in the 50-64 age category with both diabetes and depression experienced a significant acceleration in memory loss compared to individuals with only one, or neither condition.
Previous research found that having type 2 diabetes increases a person’s risk of developing depression. Conversely, having depression increases a person’s risk of developing diabetes. Both conditions are associated with an increased risk of cognitive decline and dementia. (read more)
The latest research and innovation was discussed at a global diabetes conference in the US this week, which brought together healthcare professionals with an interest in the condition.
Here is a round-up of some of the highlights which were shared at this year’s American Diabetes Association’s 77th Scientific Sessions (ADA 2017), which took place in San Diego, California. (read more)
Middle-aged adults with long-standing type 1 diabetes at high risk for cardiovascular disease who added metformin to insulin therapy for 3 years saw reductions in body weight, LDL cholesterol and atherosclerosis progression vs. those assigned placebo, according to a speaker here. (read more)